Benitec Biopharma (BNTC) Non Operating Income (2019 - 2025)

Benitec Biopharma has reported Non Operating Income for 7 years, with the latest figure at $1.5 million in Q4 2025.

• Quarterly Non Operating Income rose 22.91% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 42.84% YoY) and the FY2025 annual result came in at $3.8 million, up 325.66% from the prior year.
• Non Operating Income improved to $1.5 million in Q4 2025 per BNTC's latest filing, from $838000.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $1.5 million in Q4 2025 and troughed at -$329000.0 in Q2 2022.
• A 5-year average of $347850.0 and a median of $130500.0 in 2021 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2021 and 2025: Non Operating Income slumped 1388.89% in 2021, then soared 20950.0% in 2025.
• Over 5 years, Non Operating Income stood at $14000.0 in 2021, then jumped by 1321.43% to $199000.0 in 2022, then tumbled by 35.18% to $129000.0 in 2023, then soared by 871.32% to $1.3 million in 2024, then rose by 22.91% to $1.5 million in 2025.
• According to Business Quant data, Non Operating Income over the past three periods registered $1.5 million, $838000.0, and $1.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.